.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Set up watchlists for daily email updates

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
QuintilesIMS
Merck
Harvard Business School
Deloitte
Queensland Health
Citi
Mallinckrodt
Boehringer Ingelheim
Fish and Richardson

Generated: June 24, 2017

DrugPatentWatch Database Preview

ZAFIRLUKAST Drug Profile

« Back to Dashboard

What is the patent landscape for Zafirlukast, and when can generic versions of Zafirlukast launch?

Zafirlukast is a drug marketed by Dr Reddys Labs Ltd and is included in one NDA.

The generic ingredient in ZAFIRLUKAST is zafirlukast. There are two drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the zafirlukast profile page.

Summary for Tradename: ZAFIRLUKAST

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list3
Bulk Api Vendors: see list68
Clinical Trials: see list4
Patent Applications: see list3,991
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ZAFIRLUKAST at DailyMed

Pharmacology for Tradename: ZAFIRLUKAST

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dr Reddys Labs Ltd
ZAFIRLUKAST
zafirlukast
TABLET;ORAL090372-001Nov 18, 2010ABRXNoNo► Subscribe► Subscribe
Dr Reddys Labs Ltd
ZAFIRLUKAST
zafirlukast
TABLET;ORAL090372-002Nov 18, 2010ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Merck
Argus Health
Chubb
Boehringer Ingelheim
Dow
Federal Trade Commission
Teva
McKinsey
AstraZeneca
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot